Showing results (61-70 of 641) with videos related to

Sort By:
Pageof 65
Arthritis and Rheumatism|March 20, 1998
Churg-Strauss syndrome: serum markers of lymphocyte activation and endothelial damageW H Schmitt, E Csernok, S Kobayashi, et al.
Journal of Leukocyte Biology|April 20, 2001
The endotoxin-binding bactericidal/permeability-increasing protein (BPI): a target antigen of autoantibodiesH Schultz, J Weiss, S F Carroll, et al.
Clinical and Experimental Immunology|October 27, 2001
Increased expression of CTLA-4 (CD152) by T and B lymphocytes in Wegener's granulomatosisK Steiner, F Moosig, E Csernok, et al.
Advances in Experimental Medicine and Biology|January 1, 1993
In vitro interactions of c-ANCA (antibodies to proteinase 3) with human endothelial cellsW J Mayet, E M Hermann, E Csernok, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1994
Anti-neutrophil cytoplasmic antibodies engage and activate human neutrophils via Fc gamma RIIaA J Porges, P B Redecha, W T Kimberly, et al.
Clinical and Experimental Immunology|May 2, 2002
Elevated monocytic IL-12 and TNF-alpha production in Wegener's granulomatosis is normalized by cyclophosphamide and corticosteroid therapyP Lamprecht, G Kumanovics, A Mueller, et al.
The Journal of Experimental Medicine|October 1, 1996
Neutrophil activation by anti-proteinase 3 antibodies in Wegener's granulomatosis: role of exogenous arachidonic acid and leukotriene B4 generationF Grimminger, K Hattar, C Papavassilis, et al.
Arthritis and Rheumatism|April 22, 1999
Cytokine profiles in Wegener's granulomatosis: predominance of type 1 (Th1) in the granulomatous inflammationE Csernok, A Trabandt, A Müller, et al.
Clinical and Experimental Rheumatology|January 27, 2004
Prevalence of ANCA in mixed cryoglobulinemia and chronic hepatitis C virus infectionP Lamprecht, O Gutzeit, E Csernok, et al.
Pageof 65